Interpersonal Psychotherapy for Depression in Parkinson’s Disease: A Feasibility Study

Individuals living with Parkinson’s disease (PD) experience interpersonal stressors that contribute to depressive risk. Interpersonal psychotherapy (IPT) emphasizes the bidirectional relationship between interpersonal stressors and mood may therefore be a suitable treatment for PD-depression. The pr...

Full description

Saved in:
Bibliographic Details
Published in:Journal of geriatric psychiatry and neurology 2023-01, Vol.36 (1), p.52-62
Main Authors: Koszycki, Diana, Taljaard, Monica, Kogan, Cary, Bradwejn, Jacques, Grimes, David
Format: Article
Language:English
Subjects:
Depression - complications
Depression - therapy
Depressive Disorder, Major - complications
Depressive Disorder, Major - therapy
Feasibility Studies
Humans
Interpersonal Psychotherapy
Interpersonal Relations
Original
Parkinson Disease - complications
Parkinson Disease - therapy
Psychotherapy
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Individuals living with Parkinson’s disease (PD) experience interpersonal stressors that contribute to depressive risk. Interpersonal psychotherapy (IPT) emphasizes the bidirectional relationship between interpersonal stressors and mood may therefore be a suitable treatment for PD-depression. The primary aim of this study was to evaluate the feasibility of delivering 12 sessions of IPT to depressed PD patients and explore the need for modifications. A secondary aim was to obtain descriptive information about efficacy outcomes. The study used a pre-post design without a comparison group. Participants were 12 PD patients with a major depressive disorder. IPT was well accepted and tolerated by patients and required minimal modifications. Compliance with session attendance and completion of study questionnaires were excellent and treatment satisfaction was high. Depression scores declined from baseline to endpoint, with 7 patients meeting criteria for remission at endpoint. Findings are encouraging and a larger randomized controlled trial is currently underway to ascertain if IPT is an efficacious treatment for PD-depression.
ISSN:0891-9887
1552-5708
DOI:10.1177/08919887221090220